featured
featured · page 6
- Medical
Vast majority of Germans pro-medical cannabis as election looms, poll shows
80% of Germans favour medical cannabis as pro-reform parties eye big gains in September’s poll.
- CBD Market
Wellness brand Prima rakes in $9.2m in big funding round
The American firm is targeting retail expansion and new trials.
- Uncategorized
Jane West: Mum who was fired for using cannabis built her own empire
The entrepreneur and founder of Women Grow is determined to change the narrative around cannabis
- Companies
Cannabis firms unite to demand robust UK industry
Almost 100 major organisations have joined a new industry body
- Uncategorized
Amazon announces support for cannabis legalisation
The company will be “actively supporting” federal legislation and dropping drug testing for some employees.
- Companies
The UK start-up taking on the cannabis industry’s big beasts
The start-up is positioning itself to take on established companies as the European market heats up
- News
Calls for reform of ‘unfair’ tax code facing cannabis firms
Business leaders are calling for reform of the Section 280E tax code, which prevents firms deducting business costs from income associated with the “trafficking” of controlled drugs.
- Medical
Denmark latest European country to back the medical cannabis industry
Danish politicians have agreed to extend a medical cannabis programme – and North America’s giants are watching
- Medical
Another North American medical cannabis company sets up shop in Europe
Canadian company Zyus’ deal to enter Portugal is another indication the global industry is watching Europe
- CBD Market
Are CBD-infused cosmetics the industry’s next big trend?
New report says the industry is set to grow in the US but can we expect the same in Europe?
- CBD Market
Love Hemp announce £2m investment boost and celebrate record sales
The UK-based CBD company has been carrying out major fundraising activities this year
- Policy & Regulation
Cross-party Westminster group demand Misuse of Drugs Act is overhauled
There is broad support for reform on the 50th anniversary of the controversial act’s passage into law
